Differential metabolomic signatures of declining renal function in Types 1 and 2 diabetes.
暂无分享,去创建一个
C. Forsblom | P. Groop | E. Ferrannini | N. Sandholm | A. Solini | M. Manca | J. Haukka | Jani K. Haukka
[1] S. Hadjadj,et al. Association of Circulating Biomarkers (Adrenomedullin, TNFR1, and NT-proBNP) With Renal Function Decline in Patients With Type 2 Diabetes: A French Prospective Cohort , 2016, Diabetes Care.
[2] V. Gebski,et al. Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study , 2011, Diabetologia.
[3] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[4] C. Forsblom,et al. Metabolomic Profile Predicts Development of Microalbuminuria in Individuals with Type 1 Diabetes , 2018, Scientific Reports.
[5] T. Meyer,et al. Uremic solutes and risk of end stage renal disease in type 2 diabetes , 2014, Kidney international.
[6] C. Forsblom,et al. The serum uric acid concentration is not causally linked to diabetic nephropathy in type 1 diabetes. , 2017, Kidney international.
[7] Keith C. Norris,et al. Albuminuria, serum creatinine, and estimated glomerular filtration rate as predictors of cardio-renal outcomes in patients with type 2 diabetes mellitus and kidney disease: a systematic literature review , 2018, BMC Nephrology.
[8] P. Lotufo,et al. Metabolites related to eGFR: Evaluation of candidate molecules for GFR estimation using untargeted metabolomics. , 2019, Clinica chimica acta; international journal of clinical chemistry.
[9] B. Kestenbaum,et al. Kidney disease and increased mortality risk in type 2 diabetes. , 2013, Journal of the American Society of Nephrology : JASN.
[10] F. Vaz,et al. Acylcarnitines , 2012, Diabetes.
[11] Q. Lou,et al. Serum uric acid to creatinine ratio: A predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function , 2017, Diabetes & vascular disease research.
[12] L. Krishnamurti,et al. Acute renal failure from xanthine nephropathy during management of acute leukemia , 2007, Pediatric Nephrology.
[13] F. Tsai,et al. Identification of Urinary Metabolite Biomarkers of Type 2 Diabetes Nephropathy Using an Untargeted Metabolomic Approach. , 2018, Journal of proteome research.
[14] H. Mischak,et al. Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial , 2016, BMJ Open.
[15] U. Boggi,et al. Mast cells infiltrate pancreatic islets in human type 1 diabetes , 2015, Diabetologia.
[16] E. Ferrannini,et al. Prediction of Declining Renal Function and Albuminuria in Patients With Type 2 Diabetes by Metabolomics. , 2016, The Journal of clinical endocrinology and metabolism.
[17] R. MacIsaac,et al. Spectrum of renal disease in diabetes , 2014, Nephrology.
[18] D. Green. Apoptosis and Sphingomyelin Hydrolysis , 2000, The Journal of cell biology.
[19] J. Bonventre,et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease , 2017, Diabetes Care.
[20] Y. Li,et al. Metabolic profiling of urine in young obese men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC/Q-TOF MS). , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[21] J. Coyle,et al. Global Biochemical Profiling Identifies β-Hydroxypyruvate as a Potential Mediator of Type 2 Diabetes in Mice and Humans , 2014, Diabetes.
[22] G. Roh,et al. N-acetylcysteine attenuates glycerol-induced acute kidney injury by regulating MAPKs and Bcl-2 family proteins. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[23] Seiji Yasumura,et al. Corrigendum to “Evacuation after the Fukushima Daiichi Nuclear Power Plant Accident Is a Cause of Diabetes: Results from the Fukushima Health Management Survey” , 2015, Journal of diabetes research.
[24] R. Vasan,et al. Risk of ESRD and Mortality Associated With Change in Filtration Markers. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[25] Giuseppe Palermo,et al. Performance of PLS regression coefficients in selecting variables for each response of a multivariate PLS for omics-type data , 2009, Advances and applications in bioinformatics and chemistry : AABC.
[26] C. Kent. The Effect of Social Media in Social Interaction , 2019 .
[27] T. Wang,et al. Histamine promotes the differentiation of macrophages from CD11b+ myeloid cells and formation of foam cells through a Stat6-dependent pathway. , 2017, Atherosclerosis.
[28] T. Ideker,et al. Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. , 2013, Journal of the American Society of Nephrology : JASN.
[29] Merlin C. Thomas,et al. Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). , 2005, Diabetes care.
[30] P. Conti,et al. Impact of mast cells in mucosal immunity of intestinal inflammation: Inhibitory effect of IL‐37 , 2018, European journal of pharmacology.
[31] Rury R Holman,et al. Risk Factors for Renal Dysfunction in Type 2 Diabetes , 2006, Diabetes.
[32] M. Woodward,et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis , 2012, The Lancet.
[33] E. Tai,et al. Profiling of Plasma Metabolites Suggests Altered Mitochondrial Fuel Usage and Remodeling of Sphingolipid Metabolism in Individuals With Type 2 Diabetes and Kidney Disease , 2016, Kidney international reports.
[34] P. Stenvinkel,et al. Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease , 2010, Journal of internal medicine.
[35] S. Navaneethan,et al. Impact of Uric Acid Levels on Kidney Disease Progression , 2017, American Journal of Nephrology.
[36] G. Zoppini,et al. Hypertriglyceridemia Is Independently Associated with Renal, but Not Retinal Complications in Subjects with Type 2 Diabetes: A Cross-Sectional Analysis of the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study , 2015, PloS one.
[37] J. Nicholson. Global systems biology, personalized medicine and molecular epidemiology , 2006, Molecular systems biology.
[38] Chi Pang Wen,et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention , 2013, The Lancet.
[39] H. Mischak,et al. Plasma and urinary amino acid metabolomic profiling in patients with different levels of kidney function. , 2014, Clinical journal of the American Society of Nephrology : CJASN.
[40] Cezmi A Akdis,et al. Immune regulation by histamine and histamine-secreting bacteria. , 2017, Current opinion in immunology.
[41] J. Adamski,et al. Metabolomics for clinical use and research in chronic kidney disease , 2017, Nature Reviews Nephrology.
[42] T. Hankemeier,et al. Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study) , 2011, Metabolomics.
[43] J. Dam,et al. Histidine Decarboxylase Deficiency Prevents Autoimmune Diabetes in NOD Mice , 2015, Journal of diabetes research.
[44] R. Townsend,et al. MicroRNA biomarkers in clinical renal disease: from diabetic nephropathy renal transplantation and beyond. , 2016, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[45] D. Zeeuw,et al. Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus , 2014, Diabetic medicine : a journal of the British Diabetic Association.